TABLE 1.

Adverse events reported by two or more subjects during the single-dose study with S/GSK1349572

AE	No. (%) of AEs with the following dosea:
	2 mg (n = 8)	5 mg (n = 7)	10 mg (n = 8)	25 mg (n = 8)	50 mg (n = 6)	100 mg (n = 5)	Placebo (n = 5)
Any AE	2 (25)	1 (14)	2 (25)	3 (38)	3 (50)	2 (40)	3 (60)
Headache	1 (13)	0	1 (13)	0	0	0	2 (40)
Somnolence	0	0	0	0	2 (33)	0	0
Drug-related AE	0	0	1 (13)	3 (38)	3 (50)	0	1 (20)
Headache	0	0	1 (13)	0	0	0	1 (20)
Somnolence	0	0	0	0	2 (33)	0	0

^an, number of subjects.